About Axogen, Inc. 
Axogen, Inc.
Pharmaceuticals & Biotechnology
AxoGen, Inc. offers surgical solutions for peripheral nerve injuries. The Company provides products and education to improve surgical treatment algorithms for peripheral nerve injuries. Its portfolio of products includes Avance Nerve Graft, AxoGuard Nerve Connector, AxoGuard Nerve Protector and Avive Soft Tissue Membrane. Along with these core surgical products, the Company also offers the AxoTouch Two-Point Discriminator, and AcroVal Neurosensory and Motor Testing System. These evaluation and measurement tools assist healthcare professionals in detecting changes in sensation; assessing return of sensory, grip and pinch function; evaluating treatment interventions, and providing feedback to patients on nerve function. Its portfolio of products is available in the United States, Canada, the United Kingdom and several European and other countries. The Company's products are used by surgeons during surgical interventions to repair a range of nerve injuries throughout the body.
Company Coordinates 
Company Details
13631 Progress Blvd Ste 400 , ALACHUA FL : 32615-9409
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 51 Schemes (26.93%)
Foreign Institutions
Held by 63 Foreign Institutions (10.93%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Ms. Karen Zaderej
Chairman of the Board, President, Chief Executive Officer
Ms. Amy Wendell
Lead Independent Director
Mr. Gregory Freitag
Director
Mr. Paul Thomas
Director
Mr. Quentin Blackford
Independent Director
Dr. Mark Gold
Independent Director
Revenue and Profits:
Net Sales:
57 Million
(Quarterly Results - Jun 2025)
Net Profit:
1 Million
Pharmaceuticals & Biotechnology
USD 738 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
0.13
-4.49%
6.57






